Trials / Completed
CompletedNCT02397499
Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat
A Multi-Center, Randomized, Double-Blinded, Placebo-Controlled Study Evaluating the Safety and Efficacy of LIPO-202 for the Reduction of Central Abdominal Bulging Due to Subcutaneous Fat in Non-Obese Subjects
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 800 (estimated)
- Sponsor
- Neothetics, Inc · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a multi-center, randomized, double-blinded, placebo-controlled study evaluating the safety and efficacy of LIPO-202 for the reduction of central abdominal bulging due to subcutaneous fat in non-obese subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | LIPO-202 | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-04-01
- Primary completion
- 2015-12-01
- First posted
- 2015-03-25
- Last updated
- 2016-01-08
Locations
31 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02397499. Inclusion in this directory is not an endorsement.